Komori
Management planning5619MRSO.,IncInformation and Communications, Services and Others

Explanatory Material on Business Plans and Growth Potential

Based on results for 2025, the company disclosed its earnings forecast for the fiscal year ending December 2026 and its growth strategy centered on business DX for medical facilities and corporate bookings. While revenue is expected to increase, operating and net losses are projected to widen as the company prioritizes growth investments.

Worth reading
40Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
17.1
Year-on-year change in net sales (%)
Wording
Avoiding a definitive answer
How definitive the wording is.

Items stated in the management plan

Annual update
Publication date 31 March 2026
Net Sales+0.0%
基準 2,025Target2,026million
Operating profit+0.0%
基準 2,025Target2,026million
Net income for the current fiscal year+0.0%
基準 2,025Target2,026million

Each line is the climb from the baseline the document states to the target it sets. The slope is scaled against the largest climb in this document. The increase shown by the dotted line is calculated from the two reported figures because the company did not provide the amount of growth.

Investment amount by sectorField Investment in people and talent / Amount Not disclosed, Field Strategic Investment / Amount Not disclosed
Key initiatives
01Growth strategy 1: Promoting business DX for medical facilities
02Expanding DX adoption
03Increasing the number of partnerships
04Growth strategy 2: Establishing a common platform for corporate health management
05Promoting business partnerships
06Expanding DX implementation support functions
07Promoting the adoption of online booking
08Expanding partner relationships by leveraging the medical facility network
Segment targetSegment Booking revenue / Fiscal year Fiscal year ending December 2026 / Target ¥725 million, Segment Advertising revenue / Fiscal year Fiscal year ending December 2026 / Target ¥347 million, Segment DX revenue / Fiscal year Fiscal year ending December 2026 / Target ¥189 million
Non-financial targetsIndicator Extending Healthy Life Expectancy / Target value 8-year extension (+8Y) / Timing Not disclosed, Indicator Number of target medical facilities / Target value Approximately 4,500 facilities / Timing Not disclosed
Size of the Target MarketMarket Health checkup and comprehensive medical examination market / Scale Approximately ¥944.0 billion / Source Yano Research Institute, "Trends and Forecasts for the Health Checkup and Comprehensive Medical Examination Market", Market Corporate market / Scale Approximately ¥600 billion / Source Not disclosed, Market Corporate health management market / Scale Approximately ¥314.0 billion / Source Company estimate, based on e-Stat's "Labour Force Survey: Basic Tabulation for All Prefectures" and Fuji Keizai's "Data Health Plans, Corporate Health Management, PHR-Related Markets and Trends among Advanced Health Insurance Societies 2021"
Risks identified by the company
Customer information management
Impact of external search engines and AI search
System failures
The risk related to "COVID-19-related sales," which had been included through the previous fiscal year, was removed because sales have declined substantially and the impact on results is limited.
Items stated in the management plan
ItemDetails
Progress against the planAnnual update
Sales Target¥1,078 million (2025 actual) → ¥1,262 million (2026 forecast)(+17.1%)
Operating profit target¥33 million loss (2025 actual) → ¥76 million loss (2026 forecast)
Net income target¥23 million loss (2025 actual) → ¥76 million loss (2026 forecast)
Investment amount by sectorField Investment in people and talent / Amount Not disclosed, Field Strategic Investment / Amount Not disclosed
Segment targetSegment Booking revenue / Fiscal year Fiscal year ending December 2026 / Target ¥725 million, Segment Advertising revenue / Fiscal year Fiscal year ending December 2026 / Target ¥347 million, Segment DX revenue / Fiscal year Fiscal year ending December 2026 / Target ¥189 million
Non-financial targetsIndicator Extending Healthy Life Expectancy / Target value 8-year extension (+8Y) / Timing Not disclosed, Indicator Number of target medical facilities / Target value Approximately 4,500 facilities / Timing Not disclosed
Key initiativesGrowth strategy 1: Promoting business DX for medical facilities, Expanding DX adoption, Increasing the number of partnerships, Growth strategy 2: Establishing a common platform for corporate health management, Promoting business partnerships, Expanding DX implementation support functions, Promoting the adoption of online booking, Expanding partner relationships by leveraging the medical facility network
Size of the Target MarketMarket Health checkup and comprehensive medical examination market / Scale Approximately ¥944.0 billion / Source Yano Research Institute, "Trends and Forecasts for the Health Checkup and Comprehensive Medical Examination Market", Market Corporate market / Scale Approximately ¥600 billion / Source Not disclosed, Market Corporate health management market / Scale Approximately ¥314.0 billion / Source Company estimate, based on e-Stat's "Labour Force Survey: Basic Tabulation for All Prefectures" and Fuji Keizai's "Data Health Plans, Corporate Health Management, PHR-Related Markets and Trends among Advanced Health Insurance Societies 2021"
Risks identifiedCustomer information management, Impact of external search engines and AI search, System failures, The risk related to "COVID-19-related sales," which had been included through the previous fiscal year, was removed because sales have declined substantially and the impact on results is limited.
Publication date31 March 2026
Items this document does not state (14)
Plan namePlan periodOperating profit margin targetROE targetROIC targetPayout ratio / DOE policyTreasury share acquisition policyCost of capitalSelf-assessment of PBR and share priceTotal investment planPlan assumptionsResults under the previous planReason for revision or withdrawalDate of board resolution

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In 2025, revenue was affected by the end of vaccine-related sales, a decline following the completion of a large development project recorded in 2024, and the impact of Google search algorithms and other factors on individual bookings. In 2026, the company expects growth in both individual and corporate bookings, higher advertising revenue driven by an increase in bookings, and the conversion of the order backlog from 2025 into sales. At the same time, it will prioritize strategic investment to accelerate market share expansion.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Explanatory Material on Business Plans and Growth Potential | MRSO.,Inc (5619) timely disclosure | Komori